Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Patterson

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|April 26, 2021
Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate VasculitisRebecca A Porritt, Carol Chase Huizar, Edward J Dick, et al.
Virology|July 4, 2006
Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responsesNina V Malkevitch, L Jean Patterson, M Kristine Aldrich, et al.
Vaccine|August 19, 2003
Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinantsJun Zhao, Yuanmei Lou, Joel Pinczewski, et al.
Scientific Reports|December 8, 2017
Experimental Zika Virus Inoculation in a New World Monkey Model Reproduces Key Features of the Human InfectionCharles Y Chiu, Claudia Sánchez-San Martín, Jerome Bouquet, et al.
Virology|January 18, 2006
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteinsPeter J Bredenbeek, Richard Molenkamp, Willy J M Spaan, et al.
Vaccine|August 12, 2008
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primatesIgor S Lukashevich, Ricardo Carrion, Maria S Salvato, et al.
Virology|February 7, 2008
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaquesL Jean Patterson, Jennifer Beal, Thorsten Demberg, et al.
Journal of Virology|February 21, 2012
Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challengePeng Xiao, L Jean Patterson, Seraphin Kuate, et al.
Emerging Infectious Diseases|November 4, 2008
Framework for leadership and training of Biosafety Level 4 laboratory workersJames W Le Duc, Kevin Anderson, Marshall E Bloom, et al.
Vaccine|May 20, 2008
Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infectionRuth H Florese, Roger W Wiseman, David Venzon, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|April 26, 2021
Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate VasculitisRebecca A Porritt, Carol Chase Huizar, Edward J Dick, et al.
Virology|July 4, 2006
Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responsesNina V Malkevitch, L Jean Patterson, M Kristine Aldrich, et al.
Vaccine|August 19, 2003
Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinantsJun Zhao, Yuanmei Lou, Joel Pinczewski, et al.
Scientific Reports|December 8, 2017
Experimental Zika Virus Inoculation in a New World Monkey Model Reproduces Key Features of the Human InfectionCharles Y Chiu, Claudia Sánchez-San Martín, Jerome Bouquet, et al.
Virology|January 18, 2006
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteinsPeter J Bredenbeek, Richard Molenkamp, Willy J M Spaan, et al.
Vaccine|August 12, 2008
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primatesIgor S Lukashevich, Ricardo Carrion, Maria S Salvato, et al.
Virology|February 7, 2008
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaquesL Jean Patterson, Jennifer Beal, Thorsten Demberg, et al.
Journal of Virology|February 21, 2012
Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challengePeng Xiao, L Jean Patterson, Seraphin Kuate, et al.
Emerging Infectious Diseases|November 4, 2008
Framework for leadership and training of Biosafety Level 4 laboratory workersJames W Le Duc, Kevin Anderson, Marshall E Bloom, et al.
Vaccine|May 20, 2008
Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infectionRuth H Florese, Roger W Wiseman, David Venzon, et al.
Pageof 5